Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-24

Clinical Trial Update: Software Treatment for Actively Reducing Severity of ADHD [NA]

View source ↗

Summary

A completed clinical trial evaluating a software-based treatment intended to actively reduce severity of ADHD. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Software treatment for ADHD (AKILI

Snippet

Sponsor: Akili Interactive Labs, Inc. | Conditions: Attention Deficit Disorder With Hyperactivity | NA | Status: COMPLETED | Results posted: 2020-07-24